In these diseases, as well as in secondary tauopathies such as AD, ARTAG with perinuclear hyperphosphorylated tau aggregates have been observed (Kahlson and Colodner, 2015; Leyns and Holtzman, 2017). Here, MAPT is linked to Alzheimer disease.